Early IL‐10 predominant responses are associated with progression to chronic hepatitis C virus infection in injecting drug users

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Viral Hepatitis

• Publication date

  2011-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1365-2893.2010.01335.xPMID 20626625PMCID PMC4277610
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effective treatment of injecting drug users with recently acquired hepatitis C virus infection.

  2010cited by this paper
• Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

  2009cited by this paper
• Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

  2009cited by this paper
• IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy

  2009cited by this paper
• Hepatitis C Virus Inhibits Cell Surface Expression of HLA-DR, Prevents Dendritic Cell Maturation, and Induces Interleukin-10 Production

  2008cited by this paper
• IL‐10 and the resolution of infections

  2008cited by this paper
• Functional suppression by FoxP3+CD4+CD25(high) regulatory T cells during acute hepatitis C virus infection.

  2008cited by this paper
• Peripheral virus-specific T-cell interleukin-10 responses develop early in acute hepatitis C infection and become dominant in chronic hepatitis.

  2008cited by this paper
• Hepatitis C virus (HCV)-specific immune responses of long-term injection drug users frequently exposed to HCV.

  2008cited by this paper
• HCV‐specific T‐cell responses in injecting drug users: evidence for previous exposure to HCV and a role for CD4+ T cells focussing on nonstructural proteins in viral clearance

  2008cited by this paper
• IL-10, T cell exhaustion and viral persistence.

  2007cited by this paper
• IL-10 or not IL-10: that is the question

  2007cited by this paper
• TH1 cells control themselves by producing interleukin-10

  2007cited by this paper
• Intrahepatic virus‐specific IL‐10‐producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection

  2006cited by this paper
• Accumulation of dysfunctional effector CD8+ T cells in the liver of patients with chronic HCV infection.

  2006cited by this paper
• Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies

  2006cited by this paper
• Resolution of a chronic viral infection after interleukin-10 receptor blockade

  2006cited by this paper
• Interleukin-10 determines viral clearance or persistence in vivo

  2006cited by this paper
• HIV-1 induces IL-10 production in human monocytes via a CD4-independent pathway.

  2005cited by this paper
• Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication

  2005cited by this paper
• Adaptive immune responses in acute and chronic hepatitis C virus infection

  2005cited by this paper
• Blocking of interleukin-10 receptor--a novel approach to stimulate T-helper cell type 1 responses to hepatitis C virus.

  2005cited by this paper
• Interfering with interferons: Hepatitis C virus counters innate immunity.

  2005cited by this paper
• Preferential loss of IL‐2–secreting CD4+ T helper cells in chronic HCV infection

  2005cited by this paper
• Neutralizing antibody response during acute and chronic hepatitis C virus infection.

  2004cited by this paper
• Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection.

  2004cited by this paper
• Subversion of effector CD8+ T cell differentiation in acute hepatitis C virus infection: exploring the immunological mechanisms

  2004cited by this paper
• An immunomodulatory role for CD4+CD25+ regulatory T lymphocytes in hepatitis C virus infection

  2004cited by this paper
• Memory CD8 T-Cell Differentiation during Viral Infection

  2004cited by this paper
• Hepatic expansion of a virus-specific regulatory CD8+ T cell population in chronic hepatitis C virus infection

  2004cited by this paper
• Relationship Between Interferon-γ, Interleukin-10, and Interleukin-12 Production in Chronic Hepatitis C and In Vitro Effects of Interferon-α

  2004cited by this paper
• Viral Persistence Alters CD8 T-Cell Immunodominance and Tissue Distribution and Results in Distinct Stages of Functional Impairment

  2003cited by this paper
• Hepatitis C Virus Core and Nonstructural Protein 3 Proteins Induce Pro- and Anti-inflammatory Cytokines and Inhibit Dendritic Cell Differentiation1

  2003cited by this paper
• CD8 T Cells Remember with a Little Help

  2003cited by this paper
• Characterization of HCV‐specific Patr class II restricted CD4+ T cell responses in an acutely infected chimpanzee

  2003cited by this paper
• Kinetics of CD4+ and CD8+ Memory T-Cell Responses during Hepatitis C Virus Rechallenge of Previously Recovered Chimpanzees

  2003cited by this paper
• Production of interleukins 10 and 12 by activated peripheral blood monocytes/macrophages in patients suffering from chronic hepatitis C virus infection with respect to the response to interferon and ribavirin treatment.

  2002cited by this paper
• [Epidemiology of hepatitis C].

  2002cited by this paper
• Impaired Effector Function of Hepatitis C Virus-Specific CD8+ T Cells in Chronic Hepatitis C Virus Infection1

  2002cited by this paper
• Broad Specificity of Virus-Specific CD4+ T-Helper-Cell Responses in Resolved Hepatitis C Virus Infection

  2002cited by this paper
• Inaugural Article: Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease

  2002cited by this paper
• Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection

  2001cited by this paper
• Interleukin-10 and the interleukin-10 receptor.

  2001cited by this paper
• Vigorous peripheral blood cytotoxic T cell response during the acute phase of hepatitis C virus infection.

  2000cited by this paper
• Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C.

  2000cited by this paper
• The role of interleukin-10 in critical illness.

  2000cited by this paper
• Relationship between interferon-gamma, interleukin-10, and interleukin-12 production in chronic hepatitis C and in vitro effects of interferon-alpha.

  2000cited by this paper
• Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus

  2000cited by this paper
• Limited humoral immunity in hepatitis C virus infection.

  1999cited by this paper
• Analysis of a successful immune response against hepatitis C virus.

  1999cited by this paper
• Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C.

  1999cited by this paper
• Production of cytokines in patients infected by hepatitis C virus

  1998cited by this paper
• Recurrence of hepatitis C virus after loss of virus specific CD4+ T cell response in acute hepatitis C

  1998cited by this paper
• Production of interleukins 10 and 12 by peripheral blood mononuclear cells (PBMC) in chronic hepatitis C virus (HCV) infection

  1997cited by this paper
• Epidemiology of hepatitis C

  1997cited by this paper
• Serum interleukin 4 and interleukin 10 levels in patients with chronic hepatitis C virus infection.

  1997cited by this paper
• Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.

  1996cited by this paper
• Immunoregulatory cytokines in chronic hepatitis C virus infection: Pre‐ and posttreatment with interferon alfa

  1996cited by this paper
• CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection

  1994cited by this paper
• Epidemiology of hepatitis.

  1965cited by this paper

• Diagnostic and immunological roles of leptin gene rs7799039 polymorphism and cytokines in COVID-19, HCV, and dual infection

  2026cites this paper
• The Interactive Role of Macrophages in Innate Immunity

  2023cites this paper
• Role of Inflammatory/Immune Response and Cytokine Polymorphisms in the Severity of Chronic Hepatitis C (CHC) before and after Direct Acting Antiviral (DAAs) Treatment

  2023cites this paper
• IFNγ is a central node of cancer immune equilibrium

  2023cites this paper
• Interleukin-10 contributes to reservoir establishment and persistence in SIV-infected macaques treated with antiretroviral therapy

  2022cites this paper
• Antiviral Activities of Interleukin-27: A Partner for Interferons?

  2022cites this paper
• Therapeutic potentials of Vachellia nilotica (L.) extracts in Hepatitis C infection: A review

  2021cites this paper
• Association Between Serum IL-6, IL-10, IL-12, and IL-23 Levels and Severity of Liver Cirrhosis

  2021cites this paper
• A STUDY OF THE RELATIONSHIP BETWEEN TOXOPLASMOSIS AND ITS EFFECT ON THE LEVEL OF THE COMPLETE BLOOD COUNT AND THE LEVEL OF INTERLEUKIN 10 AMONG ABORTED WOMEN IN THE CITY OF TIKRIT

  2021cites this paper
• HLA-G Expressing Immune Cells in Immune Mediated Diseases

  2020cites this paper
• Peripheral immunity in parkinson's disease associated to chronic infections: A report of two cases

  2020cites this paper
• Targeting metabolism to reverse T‐cell exhaustion in chronic viral infections

  2020cites this paper
• HLA-G liver expression and HLA-G extended haplotypes are associated with chronic hepatitis C in HIV-negative and HIV-coinfected patients.

  2020cites this paper
• A gene variation of Interferon Gamma Receptor-I promoter (rs1327474A>G) and chronic hepatitis C virus infection

  2019cites this paper
• Flow Cytometry Analysis to Identify Human CD8+ T Cells.

  2019cites this paper
• Molecular Mechanisms Involved in HCC Recurrence after Direct-Acting Antiviral Therapy

  2018cites this paper
• Increased killer B cells in chronic HCV infection may lead to autoimmunity and increased viral load

  2018cites this paper
• Cytokine-Modulated Natural Killer Cells Differentially Regulate the Activity of the Hepatitis C Virus

  2018cites this paper
• Genotype-related variations in proinflammatory and regulatory cytokine levels in treated and treatment-naive HCV-infected patients

  2018cites this paper
• Role of Human Macrophage Polarization in Inflammation during Infectious Diseases

  2018cites this paper
• Interleukin‐10 Directly Inhibits CD8+ T Cell Function by Enhancing N‐Glycan Branching to Decrease Antigen Sensitivity

  2018cites this paper
• Predictors of disease progression and outcome in chronic hepatitis C virus infection

  2018cites this paper
• Mononuclear phagocyte system in hepatitis C virus infection

  2018cites this paper
• The immune battlefield: The impact of inflammatory cytokines on CD8+ T-cell immunity

  2017cites this paper
• ROLE OF SERUM INTERLEUKIN – 10 AND INTERLEUKIN -28B GENE POLYMORPHISMS IN PREDICTING TREATMENT RESPONSE OF HEPATITIS C PATIENTS

  2017cites this paper
• IL-10: A Multifunctional Cytokine in Viral Infections

  2017cites this paper
• IL-10 reduces CD8 T cell antigen sensitivity during the establishment of chronic viral infection by modifying N-glycan branching

  2017cites this paper
• Association of interleukin-2, -4 and -10 with dengue severity

  2017cites this paper
• Immune regulation in chronic hepatitis C virus infection

  2016cites this paper
• A Potential Inhibitory Profile of Liver CD68+ Cells during HCV Infection as Observed by an Increased CD80 and PD-L1 but Not CD86 Expression

  2016cites this paper
• ADAPTIVE T-CELL RESPONSE IN PATHOGENESIS OF HEPATITIS C INFECTION

  2016cites this paper
• Alanine aminotransferase, HCV RNA levels and pro-inflammatory and pro-fibrogenic cytokines/chemokines during acute hepatitis C virus infection

  2016cites this paper
• Immunization with Recombinant Adenoviral Vectors Expressing HCV Core or F Proteins Leads to T Cells with Reduced Effector Molecules Granzyme B and IFN-γ: A Potential New Strategy for Immune Evasion in HCV Infection

  2015cites this paper
• Immune outcomes in the liver: Is CD8 T cell fate determined by the environment?

  2015cites this paper
• Expression of Viral Antigen by the Liver Leads to Chronic Infection Through the Generation of Regulatory T Cells

  2015cites this paper
• Non-invasive method for the evaluation of IL-6 and IL-10 levels in patients with chronic hepatitis C

  2015cites this paper
• A Jekyll and Hyde Profile: Type 1 Interferon Signaling Plays a Prominent Role in the Initiation and Maintenance of a Persistent Virus Infection.

  2015cites this paper
• Role of Macrophages in the Immunopathogenesis of HIV-1 Infection

  2015cites this paper
• Suppressive effect of interleukin 10 on priming of naive hepatitis C virus-specific CD8+ T cells.

  2015cites this paper
• An overview of effective therapies and recent advances in biomarkers for chronic liver diseases and associated liver cancer.

  2015cites this paper
• Clinical validation of IFNγ/IL-10 and IFNγ/IL-2 FluoroSpot assays for the detection of Tr1 T cells and influenza vaccine monitoring in humans

  2014cites this paper
• Dendritic Cell-Mediated, DNA-Based Vaccination against Hepatitis C Induces the Multi-Epitope-Specific Response of Humanized, HLA Transgenic Mice

  2014cites this paper
• MicroRNA‐155 controls Toll‐like receptor 3‐ and hepatitis C virus‐induced immune responses in the liver

  2014cites this paper
• Expression of HLA-G by mast cells is associated with hepatitis C virus-induced liver fibrosis.

  2014cites this paper
• Recent advances in the anti-HCV mechanisms of interferon

  2014cites this paper
• Detection of HCV-Specific IFN-γ Responses in HCV Antibody and HCV RNA Negative Injecting Drug Users

  2014influential citation
• Protection against hepatitis C infection via NK cells in highly-exposed uninfected injecting drug users.

  2014cites this paper
• A Targeted Mutation within the Feline Leukemia Virus (FeLV) Envelope Protein Immunosuppressive Domain To Improve a Canarypox Virus-Vectored FeLV Vaccine

  2013cites this paper
• Intracellular cytokine detection by fluorescence-activated flow cytometry: basic principles and recent advances.

  2013cites this paper
• The Interplay of IL-2 and IFN-in Response to HCV Peptides in Healthy High Risk Egyptian Health Care Workers : A Pilot Study

  2013cites this paper
• Correlates and characteristics of hepatitis C virus‐specific T‐cell immunity in exposed uninfected high‐risk prison inmates

  2013cites this paper
• Suppression of Virus Specific Immune Responses by IL-10 in Acute Dengue Infection

  2013cites this paper
• Macrophage and T Cell Produced IL-10 Promotes Viral Chronicity

  2013cites this paper
• T-cell responses in hepatitis B and C virus infection: similarities and differences

  2013cites this paper
• TH1 cytokine response to HCV peptides in Egyptian health care workers: a pilot study

  2013cites this paper
• Blockade of Chronic Type I Interferon Signaling to Control Persistent LCMV Infection

  2013cites this paper
• Maintenance of Th1 hepatitis C virus (HCV)‐specific responses in individuals with acute HCV who achieve sustained virological clearance after treatment

  2013cites this paper
• COMPARISON OF HCV PLUS-AND MINUS-STRAND RNA IN PBMCS OF RESPONDERS AND NON-RESPONDERS OF CHRONICALLY INFECTED PATIENTS RECEIVING RIBAVIRIN AND INTERFERON THERAPY

  2012cites this paper
• Emergence of distinct multiarmed immunoregulatory antigen-presenting cells during persistent viral infection.

  2012cites this paper
• Detection of host immune responses in acute phase sera of spontaneous resolution versus persistent hepatitis C virus infection.

  2012cites this paper
• Impaired hepatitis C virus (HCV)-specific interferon-γ responses in individuals with HIV who acquire HCV infection: correlation with CD4(+) T-cell counts.

  2012influential citation
• FUNCTION OF MYELOID DENDRITIC CELLS

  2012cites this paper
• Host Immune Responses to a Viral Immune Modulating Protein: Immunogenicity of Viral Interleukin-10 in Rhesus Cytomegalovirus-Infected Rhesus Macaques

  2012cites this paper
• Update on hepatitis C virus-specific immunity.

  2011cites this paper
• Cattle remain immunocompetent during the acute phase of foot-and-mouth disease virus infection

  2011cites this paper
• Dendritic Cell-Mediated, DNA-Based Vaccination Against Hepatitis Dendritic Cell-Mediated, DNA-Based Vaccination Against Hepatitis C Induces the Multi-Epitope-Specific Response of Humanized, C Induces the Multi-Epitope-Specific Response of Humanized, HLA Transgenic Mice HLA Transgenic Mice

  year unknowncites this paper